The company CEO is calling retail shareholders to answer questions. C'mon. Could be contracting with some phone answering company. I'm impressed.
Pryzbyl is a can-do new CEO.
ANI is already making money. We will have an earnings report with actual revenue.
ANI manufacturers the same kind of products we have as approved products and pipeline. Compatibility.
Company has made staying on NASDAQ a priority. Would you have bought in the first place if this wasn't on NASDAQ. I would not have.
There are a lot of unanswered questions about royalties and milestones. Honestly I own other biotechs in partnerships and they have not disclosed all of those terms either. If our pps was great we wouldn't be making a big deal about it.
I'm still processing all of this too but JTFM's post gave us a reality check and I thank him for it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.